MedPath

Sankyo Pharma GmbH

๐Ÿ‡ฉ๐Ÿ‡ชGermany
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

22

Active:13
Completed:9

Trial Phases

4 Phases

Phase 1:4
Phase 2:1
Phase 3:7
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (13 trials with phase data)โ€ข Click on a phase to view related trials

Phase 3
7 (53.8%)
Phase 1
4 (30.8%)
Phase 2
1 (7.7%)
Phase 4
1 (7.7%)

Olmesartan Medoxomil and Diabetic Nephropathy

Phase 3
Completed
Conditions
Type 2 Diabetes Mellitus
Diabetic Nephropathy
Proteinuria
Renal Disease
First Posted Date
2006-08-15
Last Posted Date
2006-10-09
Lead Sponsor
Sankyo Pharma Gmbh
Target Recruit Count
300
Registration Number
NCT00362960

Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension

Phase 4
Completed
Conditions
Essential Hypertension
Interventions
First Posted Date
2006-04-05
Last Posted Date
2010-12-10
Lead Sponsor
Sankyo Pharma Gmbh
Target Recruit Count
694
Registration Number
NCT00311155
Locations
๐Ÿ‡ฆ๐Ÿ‡น

University Klinik, F. Innere Medizin, Innsbruck, Austria

๐Ÿ‡ฆ๐Ÿ‡น

Diakonissen-Krankenhaus Hospital, Salzburg-Aigen, Austria

๐Ÿ‡ง๐Ÿ‡ช

Centre Hospitalier du Bois de l'Abbaye et de Hesba, Department of Intensive Care, Seraing, Belgium

and more 37 locations

Amlodipine as add-on to Olmesartan in Hypertension

Phase 3
Completed
Conditions
Essential Hypertension
First Posted Date
2005-09-22
Last Posted Date
2018-12-24
Lead Sponsor
Sankyo Pharma Gmbh
Target Recruit Count
429
Registration Number
NCT00220220

Olmesartan as an add-on to Amlodipine in Hypertension

Phase 3
Completed
Conditions
Essential Hypertension
First Posted Date
2005-09-22
Last Posted Date
2018-12-24
Lead Sponsor
Sankyo Pharma Gmbh
Target Recruit Count
632
Registration Number
NCT00220233

Olmesartan in Essential Hypertension

Phase 3
Completed
Conditions
Essential Hypertension
Interventions
First Posted Date
2005-09-16
Last Posted Date
2008-04-29
Lead Sponsor
Sankyo Pharma Gmbh
Target Recruit Count
2333
Registration Number
NCT00185172
Locations
๐Ÿ‡ฆ๐Ÿ‡น

Result Cro, Wien, Austria

๐Ÿ‡ฉ๐Ÿ‡ช

INPUT GmbG, Aachen, Germany

๐Ÿ‡ฎ๐Ÿ‡น

Biokos Farma s.r.l., Bologna, Italy

and more 5 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.